Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × Gemcitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 681 Carcinoma, Non-Small-Cell Lung 326 Neoplasms 168 Breast Neoplasms 166 Lung Neoplasms 157 Urinary Bladder Neoplasms 154 Neoplasm Metastasis 140 Cholangiocarcinoma 109 Ovarian Neoplasms 103 Biliary Tract Neoplasms 92 Lymphoma, Large B-Cell, Diffuse 72 Nasopharyngeal Carcinoma 70 Lymphoma 66 Sarcoma 63 Recurrence 62 Gallbladder Neoplasms 61 Carcinoma, Transitional Cell 55 Triple Negative Breast Neoplasms 53 Hodgkin Disease 52 Colorectal Neoplasms 49 Lymphoma, Non-Hodgkin 47 Fallopian Tube Neoplasms 47 Adenocarcinoma 45 Bile Duct Neoplasms 40 Carcinoma, Ovarian Epithelial 31 Non-Muscle Invasive Bladder Neoplasms 30 Uterine Cervical Neoplasms 28 Carcinoma 28 Unspecified Adult Solid Tumor, Protocol Specific 27 Adenocarcinoma of Lung 27

Interventions

Fulvestrant 18 Letrozole 10 Anastrozole 8 Capecitabine 5 palbociclib 4 olaparib 4 Docetaxel 4 pyrotinib 3 exemestane 3 Vinorelbine 3 Paclitaxel 3 Goserelin 3 Aromatase Inhibitors 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2 ribociclib 2 eribulin 2 elacestrant 2 dalpiciclib 2 abemaciclib 2 Trastuzumab 2 Injections 2 Gonadotropin-Releasing Hormone 2 FCN-437c 2 Everolimus 2 Dasatinib 2 Alpelisib 2 Albumin-Bound Paclitaxel 2 AZD9833 2 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03025880 2023-04-03

PANGEA

Spanish Breast Cancer Research Group

Phase 2 Completed

36 enrolled 28 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡